Literature DB >> 14680622

The role of mast cells in common gastrointestinal diseases.

Ali A Siddiqui1, Philip B Miner.   

Abstract

The gastrointestinal tract is a rich source of mast cells with an enormous surface area that permits a high degree of interaction between the mast cell and the intestinal contents. The active metabolic products of the mast cell influence gastrointestinal secretion, absorption, and motility through paracrine effects of local mast cell activation and also cause systemic effects through the release of cellular products into the bloodstream. Recent advances in our knowledge of the immune system and the recognition that the gastrointestinal immune function might be partially mediated through gastrointestinal mucosal mast cells has opened mast cell research to the field of gastroenterology. Local gastrointestinal proliferation of mast cells in response to recognized or obscure stimuli can alter gastrointestinal function and induce systemic symptoms. Symptoms can arise from the increased number of mast cells, overproduction of specific mast cell mediators, and hyperactivity of the enteric nervous system that induces mast cell activation. The diseases mentioned in this review represent a small proportion of areas where mast cell function might play an important role in the response to disease and generation of symptoms.

Entities:  

Mesh:

Year:  2004        PMID: 14680622     DOI: 10.1007/s11882-004-0043-z

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.919


  51 in total

1.  Mast cells and immunoglobulin E in inflammatory bowel disease.

Authors:  G Lloyd; F H Green; H Fox; V Mani; L A Turnberg
Journal:  Gut       Date:  1975-11       Impact factor: 23.059

2.  Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis.

Authors:  L B Schwartz; J W Yunginger; J Miller; R Bokhari; D Dull
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

3.  Parietal cell hyperplasia induced by the administration of pentagastrin (ICI 50,123) to rats.

Authors:  G P Crean; M W Marshall; R D Rumsey
Journal:  Gastroenterology       Date:  1969-08       Impact factor: 22.682

4.  Corticotropin-releasing hormone mimics stress-induced colonic epithelial pathophysiology in the rat.

Authors:  J Santos; P R Saunders; N P Hanssen; P C Yang; D Yates; J A Groot; M H Perdue
Journal:  Am J Physiol       Date:  1999-08

5.  Colonic mucosal mast cell distribution at line of demarcation of active ulcerative colitis.

Authors:  T King; W Biddle; P Bhatia; J Moore; P B Miner
Journal:  Dig Dis Sci       Date:  1992-04       Impact factor: 3.199

6.  Neuroimmune interactions in guinea pig stomach and small intestine.

Authors:  Sumei Liu; Hong-Zhen Hu; Na Gao; Chuanyun Gao; Guodu Wang; Xiyu Wang; Owen C Peck; Gordon Kim; Xiang Gao; Yun Xia; Jackie D Wood
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-09-11       Impact factor: 4.052

7.  Anaphylactic and non-anaphylactic murine IgG1 differ in their ability to bind to mast cells: relevance of proper glycosylation of the molecule.

Authors:  Eliana L Faquim-Mauro; Jacqueline F Jacysyn; Mahasti S Macedo
Journal:  Immunobiology       Date:  2003       Impact factor: 3.144

8.  Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease.

Authors:  S C Bischoff; J Wedemeyer; A Herrmann; P N Meier; C Trautwein; Y Cetin; H Maschek; M Stolte; M Gebel; M P Manns
Journal:  Histopathology       Date:  1996-01       Impact factor: 5.087

9.  Mast cells and eosinophils in the jejunal mucosa of patients with intestinal cow's milk allergy and celiac disease of childhood.

Authors:  I Kosnai; P Kuitunen; E Savilahti; P Sipponen
Journal:  J Pediatr Gastroenterol Nutr       Date:  1984-06       Impact factor: 2.839

Review 10.  Antidepressant therapy in 138 patients with irritable bowel syndrome: a five-year clinical experience.

Authors:  R E Clouse; P J Lustman; R A Geisman; D H Alpers
Journal:  Aliment Pharmacol Ther       Date:  1994-08       Impact factor: 8.171

View more
  6 in total

Review 1.  Mechanisms for amplified mediator release from colonic mast cells: implications for intestinal inflammatory diseases.

Authors:  Kim E Barrett
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

2.  Histamine, mast cells, and the enteric nervous system in the irritable bowel syndrome, enteritis, and food allergies.

Authors:  J D Wood
Journal:  Gut       Date:  2006-04       Impact factor: 23.059

3.  Alginate oligosaccharide enhances intestinal integrity of weaned pigs through altering intestinal inflammatory responses and antioxidant status.

Authors:  Jin Wan; Jiao Zhang; Daiwen Chen; Bing Yu; Zhiqing Huang; Xiangbing Mao; Ping Zheng; Jie Yu; Jun He
Journal:  RSC Adv       Date:  2018-04-10       Impact factor: 4.036

Review 4.  Neuropathophysiology of functional gastrointestinal disorders.

Authors:  Jackie D Wood
Journal:  World J Gastroenterol       Date:  2007-03-07       Impact factor: 5.742

Review 5.  Stress-related modulation of inflammation in experimental models of bowel disease and post-infectious irritable bowel syndrome: role of corticotropin-releasing factor receptors.

Authors:  Cornelia Kiank; Yvette Taché; Muriel Larauche
Journal:  Brain Behav Immun       Date:  2009-08-19       Impact factor: 7.217

6.  Early weaning stress impairs development of mucosal barrier function in the porcine intestine.

Authors:  Feli Smith; Jessica E Clark; Beth L Overman; Christena C Tozel; Jennifer H Huang; Jean E F Rivier; Anthony T Blikslager; Adam J Moeser
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11-19       Impact factor: 4.052

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.